Process View
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cerebral cortex development"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PEX14 | peroxisomal biogenesis factor 14 | 0.937 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.918 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.848 | ||
| PEX19 | peroxisomal biogenesis factor 19 | 0.577 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.555 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.527 | ||
| LAMB1 | laminin, beta 1 | 0.500 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.440 | Human | |
| PAX3 | paired box 3 | 0.348 | ||
| PAFAH1B1 | platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) | 0.341 | ||
| TSC2 | tuberous sclerosis 2 | 0.309 | ||
| NDEL1 | nudE nuclear distribution gene E homolog (A. nidulans)-like 1 | 0.301 | Human Mouse | |
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.287 | ||
| AXIN1 | axin 1 | 0.265 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.219 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.193 | ||
| GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.171 | Rat | |
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.162 | ||
| CPE | carboxypeptidase E | 0.144 | ||
| BCL2L1 | BCL2-like 1 | 0.142 | ||
| BBS2 | Bardet-Biedl syndrome 2 | 0.138 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.137 | ||
| MAPT | microtubule-associated protein tau | 0.137 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.128 | ||
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.123 | ||
| ASB2 | ankyrin repeat and SOCS box containing 2 | 0.118 | ||
| VEGFA | vascular endothelial growth factor A | 0.111 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.111 | ||
| APP | amyloid beta (A4) precursor protein | 0.108 | ||
| SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.107 | ||
| SNAPIN | SNAP-associated protein | 0.102 | ||
| SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | 0.099 | Mouse | |
| PEX12 | peroxisomal biogenesis factor 12 | 0.098 | ||
| CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.098 | Mouse | |
| RPL18A | ribosomal protein L18a | 0.096 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.087 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.084 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.073 | ||
| APC | adenomatous polyposis coli | 0.072 | ||
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.071 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.062 | ||
| MAP1A | microtubule-associated protein 1A | 0.059 | ||
| BICD1 | bicaudal D homolog 1 (Drosophila) | 0.057 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.051 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.049 | ||
| TMEM173 | transmembrane protein 173 | 0.048 | ||
| LAMA4 | laminin, alpha 4 | 0.046 | ||
| RTKN | rhotekin | 0.045 | ||
| COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | 0.044 | ||
| DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 0.044 | ||
| ASB7 | ankyrin repeat and SOCS box containing 7 | 0.042 | ||
| RNF144B | ring finger protein 144B | 0.041 | ||
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.040 | ||
| PAX8 | paired box 8 | 0.040 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.039 | ||
| PCDHA4 | protocadherin alpha 4 | 0.038 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.037 | ||
| PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0.034 | ||
| GRIN2A | glutamate receptor, ionotropic, N-methyl D-aspartate 2A | 0.032 | Rat | |
| CLIP1 | CAP-GLY domain containing linker protein 1 | 0.030 | ||
| PKP4 | plakophilin 4 | 0.029 | ||
| C14orf129 | chromosome 14 open reading frame 129 | 0.029 | ||
| CKAP5 | cytoskeleton associated protein 5 | 0.028 | ||
| BBS9 | Bardet-Biedl syndrome 9 | 0.025 | ||
| NIN | ninein (GSK3B interacting protein) | 0.025 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.024 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.024 | ||
| CUL2 | cullin 2 | 0.024 | ||
| TNRC6A | trinucleotide repeat containing 6A | 0.023 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.021 | ||
| GATAD2B | GATA zinc finger domain containing 2B | 0.021 | ||
| FOXD3 | forkhead box D3 | 0.020 | ||
| PCM1 | pericentriolar material 1 | 0.020 | ||
| E2F1 | E2F transcription factor 1 | 0.019 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.019 | ||
| DEFA1 | defensin, alpha 1 | 0.019 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.019 | ||
| RNR2 | l-rRNA | 0.019 | ||
| EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.018 | ||
| NCK2 | NCK adaptor protein 2 | 0.018 | ||
| FBN1 | fibrillin 1 | 0.018 | ||
| EIF2C1 | eukaryotic translation initiation factor 2C, 1 | 0.018 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.018 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.018 | ||
| SIX3 | SIX homeobox 3 | 0.017 | ||
| NLGN1 | neuroligin 1 | 0.017 | ||
| ATN1 | atrophin 1 | 0.017 | ||
| RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.017 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.017 | ||
| CDK5 | cyclin-dependent kinase 5 | 0.016 | Mouse | |
| TTC8 | tetratricopeptide repeat domain 8 | 0.016 | ||
| ASB1 | ankyrin repeat and SOCS box containing 1 | 0.016 | ||
| EXOC7 | exocyst complex component 7 | 0.016 | ||
| NTF4 | neurotrophin 4 | 0.016 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.016 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.015 | ||
| KIF1C | kinesin family member 1C | 0.015 | ||
| ATXN3 | ataxin 3 | 0.015 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.015 | ||
| XPNPEP1 | X-prolyl aminopeptidase (aminopeptidase P) 1, soluble | 0.014 | ||
| HDAC7 | histone deacetylase 7 | 0.014 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.013 | ||
| PAX6 | paired box 6 | 0.013 | Mouse | |
| KIAA1191 | KIAA1191 | 0.013 | ||
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.013 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.013 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.013 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.013 | ||
| KIAA1377 | KIAA1377 | 0.013 | ||
| KIF5B | kinesin family member 5B | 0.013 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.013 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.013 | ||
| SYNE1 | spectrin repeat containing, nuclear envelope 1 | 0.012 | ||
| NCSTN | nicastrin | 0.012 | ||
| KALRN | kalirin, RhoGEF kinase | 0.011 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.011 | ||
| CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 0.011 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.011 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.011 | ||
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.011 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.011 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.011 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.011 | ||
| LHX2 | LIM homeobox 2 | 0.011 | Mouse | |
| ASB6 | ankyrin repeat and SOCS box containing 6 | 0.011 | ||
| SUV39H1 | suppressor of variegation 3-9 homolog 1 (Drosophila) | 0.010 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.010 | ||
| LPL | lipoprotein lipase | 0.010 | ||
| BTBD1 | BTB (POZ) domain containing 1 | 0.010 | ||
| GTSE1 | G-2 and S-phase expressed 1 | 0.010 |